Granules India Ltd share price logo

Granules India Ltd

NSE: GRANULES

BSE: 532482

Small Cap

Pharma Sector

₹853.20

-19.40

(-2.22%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Granules India shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-9%

Searches for Granules India on INDmoney have decreased by 9% over the last 30 days.

Investment activity on INDmoney

+4.51%

Investment activity in Granules India among INDmoney users has increased by 4.51% over the last 30 days.

Among the most traded stocks

162nd

Granules India was the 162nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

38 days

INDmoney investors hold Granules India shares for an average of 38 days.

Key Events for Granules India

Last Dividend Declared

₹1.75 per share, declared on 29/04/2026

View Dividend History

Granules India Stock Performance

as on September 16, 2026 at 6:33 pm IST

  • Day's Low

    Day's High

    ₹845.85
    ₹872.00
    downward going graph

    0.86%

    Downside

    2.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹510.55
    ₹914.85
    downward going graph

    40.16%

    Downside

    7.23%

    Upside

    downward going graph

Granules India share price movements today

Previous Close
₹872.60
Open
₹852.55
Volume
12.32L
Upper Circuit
₹1,047.10
Lower Circuit
₹698.10
Day's Low - High
₹845.85 - ₹872.00
52 Week Low - High
₹510.55 - ₹914.85

Granules India Historical Returns

1 Month Return
+ 1.28 %
3 Month Return
+ 16.6 %
1 Year Return
+ 61.65 %
3 Year Return
+ 166.93 %
5 Year Return
+ 162.04 %

Granules India Fundamentals

as on September 16, 2026 at 1:03 pm IST

Market Cap

₹21,622.76 Cr

Return on Equity (ROE)

10.27

PE Ratio (TTM)

33.6

Return on capital employed (ROCE)

12.46

Industry PE ratio

51.81

Beta (LTM)

0.81

P/B Ratio

3.82

Dividend Yield

0.28

PEG Ratio

4.61

Quarterly Earnings Growth YOY

59.77

EPS (TTM)

24.01

Book Value

190.45

Granules India Stock Valuation

as on September 16, 2026 at 1:03 pm IST

Granules India in the last 5 years

  • Overview

  • Trends

Lowest (8.05x)

July 25, 2019

Today (33.60x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (35.36x)

August 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 33.60x

Granules India Technical Analysis

Track how Granules India technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish13
Bullish1
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-0.8
Bearish
CCI (20)
309.81
Bearish
RSI (14)
36.3
Neutral
Momentum (10)
-1.1
Bullish
ADI (14)
30.77
Bearish
Ultimate Oscillator (7,14,28)
25.77
Bearish

Moving Averages

Name

Value

Action

SMA (20)
852.81
Bearish
EMA (20)
853.01
Bearish
VWMA (20)
852.68
Bearish
SMA (50)
854.73
Bearish
EMA (50)
854.65
Bearish
SMA (200)
855.73
Bearish
EMA (200)
858.05
Bearish
KAMA (200)
854.07
Bearish
DEMA (200)
852.79
Bearish

Granules India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Granules India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Granules India Ltd image
Granules India Ltd
BUY21,622.7632.41%0.625955,365
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,206.82-4.25%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,120.3612.3%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,101.01-7.47%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,764.7444.58%0.682811,703
See all

Market expectation of Granules India Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Granules India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
1,188
1,149.71
1,169.06
1,169.11
956.52
1,133.52
1,196.82
1,208.79
1,294.67
1,378.02
1,457.43
1,464.97
Other Income
1.53
0.65
1.87
2.06
3.26
5.68
32.67
16.35
-1.15
-3.64
24.69
2.27
Total Income
1,191.02
1,156.24
1,177.65
1,181.93
969.87
1,143.37
1,230.1
1,226.45
1,295.84
1,384.3
1,495.3
1,479.04
Expenses
976.51
905.1
920.08
920.6
763.3
907.41
945.07
989.3
1,018.76
1,079.84
1,118.51
1,137.87
Operating Profit
211.49
244.61
248.98
248.51
193.22
226.11
251.75
219.49
275.91
298.18
338.92
327.1
Operating Profit Margin %
17.8%
21.28%
21.3%
21.26%
20.2%
19.95%
21.03%
18.16%
21.31%
21.64%
23.25%
22.33%
Profit Before Interest, Tax and Depreciation
214.5
251.13
257.58
261.33
206.57
235.97
285.03
237.15
277.08
304.46
376.79
341.18
Interest
25.96
28.65
28.76
27.02
25.67
26.57
23.98
23.78
29.19
28.69
32.69
21.12
Depreciation
52.52
52.39
53.18
52.87
52.52
56.61
63.5
68.85
72.02
73.53
81.75
79.65
Profit Before Tax
136.02
170.09
175.64
181.44
128.38
152.79
197.55
144.52
175.87
202.24
262.35
240.41
Tax Paid
33.91
44.45
46
46.79
31.15
35.19
45.52
31.88
45.26
52.03
60.79
60.44
Profit After Tax
102.12
125.65
129.65
134.65
97.23
117.6
152.03
112.64
130.61
150.21
201.57
179.96
Total Net profit including share of profit / Loss from associate company
102.12
125.65
129.65
134.65
97.23
117.6
152.03
112.64
130.61
150.21
201.57
179.96
EPS
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
8.23
7.26
Actual EPS
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
8.23
7.26
Adjusted EPS
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
8.23
7.26
Diluted EPS
4.22
5.18
5.35
5.55
4.01
4.85
6.27
4.64
5.38
6.19
8.23
7.12

Granules India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,684.62
2,279.2
2,598.65
3,237.54
3,764.92
4,511.92
4,490.16
4,455.97
5,338.92
Other Income
26.83
75.43
89.79
26.88
17.61
13.78
4.4
43.67
20.33
Total Income
1,711.45
2,354.62
2,688.43
3,264.42
3,782.53
4,525.7
4,510.77
4,525.28
5,385.97
Expenses
1,406.2
1,895.16
2,073.33
2,382.31
3,042.68
3,598.1
3,650.39
3,536.37
4,190.49
Operating Profit
278.42
384.04
525.32
855.23
722.24
913.82
839.77
919.6
1,148.43
Operating Profit Margin %
16.53%
16.85%
20.22%
26.42%
19.18%
20.25%
18.7%
20.64%
21.51%
Profit Before Interest, Tax and Depreciation
305.25
459.46
615.1
882.11
739.85
927.6
860.38
988.91
1,195.48
Interest
33.06
28.46
27.02
26.28
23.21
55.93
105.82
103.24
114.35
Depreciation
76.2
105.48
136.95
151.46
158.63
184.49
207.33
225.5
296.14
Profit Before Tax
195.99
325.52
451.13
704.37
558.01
687.18
547.23
660.17
784.99
Tax Paid
63.4
89.11
115.73
154.9
145.25
170.58
141.92
158.65
189.96
Profit After Tax
132.59
236.41
335.4
549.46
412.76
516.6
405.31
501.52
595.02
Total Net profit including share of profit / Loss from associate company
132.59
236.41
335.4
549.46
412.76
516.6
405.31
501.52
595.02
EPS
5.49
9.3
13.19
22.05
16.66
21.05
16.73
20.69
24.47
Actual EPS
5.49
9.3
13.19
22.05
16.66
21.05
16.73
20.69
24.47
Adjusted EPS
5.49
9.3
13.19
22.05
16.66
21.05
16.73
20.69
24.47
Diluted EPS
5.47
9.28
13.15
21.95
16.6
21
16.72
20.68
24.46

Granules India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
151.43
188.24
-0.65
262.24
476.19
432.48
332.06
738.75
439.41
866.57
793.25
Cash Flow from Investing Activities
-161.65
-326.08
-462.31
-269.81
-160.42
-277.25
-379.17
-191.62
-357.54
-689.04
-758.41
Cash Flow from Financing Activities
85.66
55.88
528.61
-17.43
-212.86
-299.31
190
-440.31
7.65
-92.5
379.29
Net Cash Flow
75.44
-81.98
65.66
-25.01
102.9
-144.09
142.88
106.84
89.54
85.01
414.12

Granules India Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Feb 2026
Mar 2026
Jun 2026
Promoters
41.96%
41.96%
38.87%
38.87%
38.85%
38.84%
38.82%
38.82%
38.82%
38.02%
38.02%
38.02%
DII
10.14%
10.7%
14.12%
14.87%
19.57%
22.45%
22.74%
17.92%
17.48%
18.51%
17.01%
16.11%
FII
0%
19.57%
20.39%
19.49%
15.87%
15.15%
0%
14.09%
13.55%
13.79%
15.31%
17.5%
Public
29.1%
27.76%
26.62%
26.78%
25.71%
23.57%
24.41%
29.17%
30.15%
29.69%
29.66%
28.38%
Total Outstanding Shares
24,23,68,716
24,23,68,716
24,23,68,716
24,23,68,716
24,24,93,716
24,25,43,716
24,26,43,716
24,26,68,716
24,26,68,716
24,77,96,921
24,77,96,921
24,77,96,921
Total Shareholders
1,90,691
1,82,142
1,79,870
2,02,198
1,77,554
1,69,802
1,69,700
1,65,542
1,63,184
1,63,818
1,60,286
1,69,422

Mutual Funds Buying / Exiting Granules India

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Granules India

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Aditya Birla Sun Life Small Cap Fund Direct Plan Growth

Aditya Birla Sun Life Small Cap Fund Direct Plan Growth

₹120.62 Cr

₹25.32 Cr (+26.57%)

1.88%

Mutual Funds Exiting Granules India

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Granules India Corporate Actions

View detailed summary of the earnings and dividend history of Granules India.

  • Granules India Ltd Earnings Results

    Granules India Ltd’s net profit jumped 59.77% since last year same period to ₹179.96Cr in the Q1 2026-2027. On a quarterly growth basis, Granules India Ltd has generated -10.72% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Granules India Ltd Dividends April,2026

    In the quarter ending March 2026, Granules India Ltd has declared dividend of ₹1.75 per share on 29 Apr 2026 - translating a dividend yield of 0.19%.

    Read More about Dividends

Indices Featuring Granules India Stock

Check stock indices that include Granules India.

S&P BSE 400 MidSmallCap

₹12,401.66

-5.18 (▲0.04%)

BSE Healthcare

₹50,319.11

-159.70 (▲0.32%)

Nifty Smallcap 250

₹17,857.90

-34.90 (▲0.20%)

Nifty 500

₹22,549.60

+72.15 (▲0.32%)

S&P BSE 250 SmallCap

₹7,041.86

-10.76 (▲0.15%)

Nifty MidSmallcap 400

₹20,737.75

-12.95 (▲0.06%)

BSE 500

₹35,280.41

+110.79 (▲0.32%)

Insights on Granules India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.85% to 3.45% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, GRANULES stock has moved up by 61.7%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 15.31% to 17.50% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GRANULES has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GRANULES has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 38.02% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.49K Cr → 1.47K Cr (in ₹), with an average decrease of 1.1% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.66% to 28.38% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 201.57 Cr → 179.96 Cr (in ₹), with an average decrease of 10.7% per quarter

About Granules India Ltd

Granules India Limited is a large-scale vertically-integrated company found in March 1991. It manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. The company has a strong presence in off-patent drugs, first-line defence products such as Paracetamol, Ibuprofen, Metformin, and Guaifenesin, as well as a global presence in over 80 countries and 250 customers. It also has a 15,000 sq. ft. research center in Pragathi Nagar, Hyderabad and has completed expansion projects in Gagillapur and Visakhapatnam. In FY 2014-15, the company crossed Rs 1200 crore in revenue, made its first acquisition, and increased its PFI capacity by 4000 tons / annum. During 2015-16 it initiated construction of 7000 TPA Metformin and 2000 TPA Guaifenesin API block, and has a total of 22 EDMF/CEP and 44 ANDA filings with US FDA. In FY 2017 the company received Establishment Inspection Report from US FDA for its Jeedimetla plant and license from the Drug Enforcement Agency for its Virginia facility. In FY 2018, it crossed Rs 1400 crore in revenue and initiated commercial production of Metaformin and Paracetamol API at its Bonthapally facility. The company also successfully received 7 ANDAs approvals from US FDA. In FY 2019, Granules India initiated buyback programme, with the Board of Directors approving a buyback of up to 12.5 million equity shares on 21 January 2020. The Company has divested its entire 50% shareholding in GranulesBiocause Pharmaceutical Co. Ltd and Granules Omnichem Private Ltd. for a consideration of Rs 111.2 crore. During the year 2021, Granules Pharmaceuticals Inc. announced a voluntary recall of 12 batches of Metformin Hydrochloride Extended Release tablets USP 750 mg, out of caution. In 2022, the Company completed the largest single manufacturing site for Multiple Unit Pellet System MUPS at its Gagillapur facility and capacity expansion for manufacturing multiple APIs at Unit V Visakhapatnam. In a span of over 30 years, Granules India has firmly established its leadership in the off-patent drugs segment, and a strong presence in first line of defense products, creating a global presence in over 80 countries, servicing over 250 customers and filing 66 EDMF/CE

Revenue: ₹1,464.97Cr as on June 2026 (Q1 FY27)
Net Profit: ₹179.96Cr as on June 2026 (Q1 FY27)
Listing date: 20 Jun, 2005
Chairperson Name: C Krishna Prasad
OrganisationGranules India Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOC Krishna Prasad
E-voting on sharesClick here to vote

FAQs

What is Granules India share price today?

Granules India share price today stands at ₹853.2 as on . Granules India share today touched a day high of ₹872 and a low of ₹845.85.

What is the 52 week high and 52 week low range for Granules India share?

Granules India touched a 52 week high of ₹914.85 and a 52 week low of ₹510.55. Granules India share price today i.e. is trending at ₹853.2, which is -6.74% down from its 52 week high and 67.11% up from its 52 week low.

What is Granules India's market capitalisation today?

Granules India market capitalisation is ₹21,622.76 Cr as on .

How to buy Granules India shares?

To buy Granules India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GRANULES or Granules India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Granules India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Granules India trading volume today?

Granules India trading volume is 12.32L as on . This means that 12.32L shares of Granules India were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Granules India shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest in Granules India has decreased while investment activity has increased over the past 30 days, and the average INDmoney investor holds the stock for 38 days. This reflects platform activity only and is not investment advice.